Trial
NCT02249078
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Eisai Inc.
Collaborators
—
Condition
Crohn's Disease
Intervention
E6011
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-05